Alibaba Health Information Technology Ltd
00241: XHKG (HKG)
| Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
|---|---|---|---|
| y@ | LOCK|G%>L | LOCK|Tp!!?bZ |
Alibaba Health Earnings: Guidance Disappoints, but Long-Term Positive Outlook Unchanged
Alibaba Health's fiscal 2026 second-half revenue growth slowed to 10% year on year but was in line with our expectations. Sales growth was driven by new drug launches and the addition of new product categories and stock-keeping units, such as GLP-1s.
